Vivos therapeutics reschedules second quarter 2023 financial results conference call

Littleton, colo., aug. 16, 2023 (globe newswire) -- vivos therapeutics, inc. (“vivos” or the “company'') (nasdaq: vvos), a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from a variety of health conditions, many of which are associated with breathing related sleep conditions arising from certain dentofacial abnormalities, today announced that the company intends to release its second quarter 2023 financial results after market close today, wednesday, august 16, 2023.
VVOS Ratings Summary
VVOS Quant Ranking